| Bid Price | 582.00p | High Price | 740.00p |
|---|
| Ask Price | 594.00p | Low Price | 572.00p |
|---|
| Open Price | 600.00p | Spread | 2.02% |
|---|
| Prev Close | 600.00p | Volume | 119,105 |
|---|
Hemogenyx Pharmaceuticals PLC Historic Prices
| Date | Open | High | Low | Close | Volume |
|---|
| Dec 8, 2025 | 477.00 | 650.00 | 470.00 | 600.00 | 99,915 |
| Dec 5, 2025 | 414.00 | 520.00 | 356.00 | 464.00 | 251,124 |
| Dec 4, 2025 | 520.00 | 520.00 | 392.00 | 412.50 | 127,509 |
| Dec 3, 2025 | 570.00 | 610.00 | 510.00 | 522.00 | 63,749 |
| Dec 2, 2025 | 618.00 | 648.00 | 572.00 | 600.00 | 30,253 |
Hemogenyx Pharmaceuticals PLC Information
| Name | Hemogenyx Pharmaceuticals PLC | Index | |
|---|
| ISIN | GB00BQVXM815 | Epic | HEMO |
|---|
| Type | Equity | Currency | GBX |
|---|
| Record Status | Active | Trading Segment | SET3 |
|---|
| Industry | Biotechnology | Sector | Healthcare |
|---|
| EMS | 300 | Trading Status | Regular Trading |
|---|
| Shares in Issue | 5.92 m | Prev Close | 600.00p |
|---|
| PE Ratio | | Market Cap | £34.44 m |
|---|
| Div Yield | 0 | Div per Share | £NaN |
|---|
| EPS | -£1.42 | Div Cover | NaN |
|---|
| PEG | n/a | EPS Growth (%) | 0.00 |
|---|
| ROCE | -1.870014 | DPS Growth (%) | 0 |
|---|
| Current Ratio | 0.430765 | Quick Ratio | 0.430765 |
|---|
Hemogenyx Pharmaceuticals PLC Director Deals
| Declared | Type | Director | Pos. | Volume / Price | Value |
|---|
| 04/09/25 | EXR | Alexis Sandler | NED | 316,667 @ £1.80 | £570,001.00 |
| 07/08/25 | PLAC | Vladislav Sandler | CEO | 133,690 @ £1.87 | £250,000.00 |
| 13/06/25 | PLAC | Vladislav Sandler | CEO | 250,000 @ £1.81 | £451,250.00 |
| 14/05/25 | PLAC | Vladislav Sandler | CEO | 250,000 @ £1.81 | £451,250.00 |
| 30/01/20 | PLAC | Peter Redmond | NED | 555,556 @ £0.02 | £10,000.00 |
| 03/07/19 | TIN | Vladislav Sandler | CEO | 1,066,667 @ £0.00 | £0.00 |
| 12/02/18 | BUY | Adrian Thorpe Beeston | RES | 200,000 @ £0.02 | £4,200.00 |
| 07/02/18 | BUY | Vladislav Sandler | CEO | 26,800 @ £0.02 | £635.00 |
| 11/10/17 | BUY | Adrian Thorpe Beeston | RES | 400,000 @ £0.03 | £11,840.00 |
| 10/10/17 | BUY | Peter Redmond | NED | 155,000 @ £0.03 | £4,859.00 |
Hemogenyx Pharmaceuticals PLC News
